SEC Form 4 · accession 0001193125-26-394103
Pharvaris N.V. · PHVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stefan Andreas Abele
Officer — Chief Technical Ops Officer
Period of report
Sep 15, 2026
Accepted (ET)
Sep 17, 2026 · 1:22 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001830487
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 15, 2026 | M | 45,000 | $16.40 | A | 85,468 | D | |
| Common StockF1 | Sep 15, 2026 | S | 45,000 | $38.1375 | D | 40,468 | D | |
| Common StockF2 | Sep 15, 2026 | S | 1,400 | $39.2411 | D | 39,068 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $16.40 | Sep 15, 2026 | M | 45,000 | D | — | Nov 15, 2033 | Common Stock | 45,000 | 44,500 | D |
Explanation of responses
- F1The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $38.00 to $38.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F2The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $39.2150 to $39.27 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- F325% of the option vested on November 15, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.